GlobeNewswire

CTG Announces Application Advantage(TM) Solution Portfolio

Dela

Expands the availability of application portfolio management and help desk services across all industries and geographies served by the Company; reports results from current clients

BUFFALO, N.Y., May 16, 2017 (GLOBE NEWSWIRE) -- CTG (NASDAQ:CTG), a leading provider of information technology (IT) solutions and services in North America and Western Europe, announced today the formal launch of Application AdvantageTM to companies in all industries and geographies served by the Company. Recently developed as part of the Company's ONE CTG initiative, Application Advantage consolidates several existing services into a new, comprehensive solution that is designed to maximize the value, efficiency, and cost-effectiveness of the application management services it provides.

CTG's Gary Mann, Managing Director and Solution Owner, Application Advantage, commented, "I've been in the application management business for more than 35 years, and our clients in this space are facing more challenges than ever. Cloud networks, virtualization, multi-lingual support, and complexity of applications are all examples of the many issues pushing our clients' IT organizations to their limit. In this environment, the imperatives to reduce costs and improve IT team productivity have become critically important."

Mann continued, "Application Advantage is helping CTG clients work through these challenges in order to achieve the results their teams are expected to deliver. The solution is demonstrating real results for CTG clients across our served markets, including average first call resolution rates over 90 percent, call abandonment rates below five percent, and a speed to answer calls under 30 seconds-all while committing to helping our clients reduce costs."

Modular by design for added flexibility, Application Advantage helps CTG's clients maximize the value of enterprise applications through a suite of integrated assessment and roadmap, application management, and help desk services. These services help CTG clients meet their evolving business and technology needs, while reducing operational costs, creating scalable workforce capacity, improving technology as well as process efficiencies, and increasing end-user satisfaction. Services in the portfolio include:

  • Assessment and Roadmap: Leveraging Information Technology and Infrastructure Library (ITIL) and industry best practices as benchmarks, this comprehensive assessment results in a complete Report of Findings and a Performance Improvement Roadmap, which address operational processes and optimization possibilities, IT outsourcing strategy, and other opportunities based on the organization's application management and support model.
  • Application Management: Tier 2 and 3 services ensure 24x7 support for some, or all, of an organization's application portfolio by providing analysts and technicians with the technical, application, and in some cases specialized, knowledge necessary to provide troubleshooting capabilities beyond Tier 1. Designed to augment CTG's client resources, Tier 2 and 3 services are scalable to accommodate any size organization or effort.
  • Help Desk: Experienced Tier 1 help desk analysts provide "first line of defense" incident and request resolution in order to quickly and efficiently address end-user calls and improve first call resolution. Reliable help desk services allow CTG's client organizations to focus their in-house analysts' attention on more critical projects and optimization efforts.

Application Advantage engagements include dedicated account management, service level reporting, continuous process improvement initiatives, and regular quality monitoring. Additional value-add services are recommended for every project, based on client need, and can include offerings such as legacy data archiving support and access to CTG's private cloud-based network. Application Advantage offers multiple delivery approaches and provides location versatility in order to address the unique needs of each client. Delivery models currently include offshore and onshore options, while also providing 24x7 or on-demand support. Additionally, delivery of CTG's services can be decentralized/virtual, collocated, centralized on client site or in one of CTG's delivery centers, or a blended model.

"Application Advantage demonstrates our ongoing commitment to the development of industry-leading IT solutions that draw upon CTG's wide range of capabilities to help our clients meet the challenges facing their organizations and industries. It also underscores our progress in expanding our existing solutions across all lines of business-a key initiative of CTG's three-year strategic plan," said Bud Crumlish, CTG President and Chief Executive Officer.

"By building out and formalizing our expertise in areas that deliver high-value, reliable results for our clients, we are demonstrating our continued commitment to expanding our expertise in new ways that provide increased benefits to our clients," Crumlish continued.

For more information about Application Advantage, visit www.ctg.com/application-advantage or email solutions@ctg.com.

About CTG:
Over the last three decades, CTG has provided reliable IT solutions and services to more than 165 application management and help desk clients, and has supported more than 900 applications for clients in 45 countries. Delivered by expert analysts and application specialists, CTG's teams provide dependable, high-quality management, maintenance, and support for both legacy and current production applications, including specialized help desk offerings that meet the unique needs of companies in various industries, including manufacturing, energy, government, healthcare and life sciences, telecommunications, and financial services. CTG's help desk analysts currently provide support in seven languages. CTG has operations in North America, Western Europe, and India. The company regularly posts news and other important information online at www.ctg.com.

Safe Harbor Statement
This document contains certain forward-looking statements concerning the Company's current expectations as to future growth, financial outlook, business strategy and performance expectations for 2017 and three-year performance targets, a share repurchase program, and statements related to cost control, new business opportunities, financial performance, market demand, and other attributes of the Company. These statements are based upon the Company's expectations and assumptions, a review of industry reports, current business conditions in the areas where the Company does business, feedback from existing and potential new clients, a review of current and proposed legislation and governmental regulations that may affect the Company and/or its clients, and other future events or circumstances. Actual results could differ materially from the outlook guidance, expectations, and other forward-looking statements as a result of a number of factors, including among others, the availability to the Company of qualified professional staff, domestic and foreign industry competition for clients and talent, increased bargaining power of large clients, the Company's ability to protect confidential client data, the partial or complete loss of the revenue the Company generates from International Business Machines Corporation (IBM) and/or SDI International (SDI), the uncertainty of clients' implementations of cost reduction projects, the effect of healthcare reform and initiatives, the mix of work between staffing and solutions, currency exchange risks, risks associated with operating in foreign jurisdictions, renegotiations, nullification, or breaches of contracts with clients, vendors, subcontractors or other parties, the change in valuation of capitalized software balances, the impact of current and future laws and government regulation, as well as repeal or modification of such, affecting the information technology (IT) solutions and staffing industry, taxes and the Company's operations in particular, industry and economic conditions, including fluctuations in demand for IT services, consolidation among the Company's competitors or clients, the need to supplement or change our IT services in response to new offerings in the industry or changes in client requirements for IT products and solutions and other factors that involve risk and uncertainty including those listed in the Company's reports filed with the Securities and Exchange Commission as of the date of this document. Such forward-looking statements should be read in conjunction with the Company's disclosures set forth in the Company's 2016 Form 10-K, which is incorporated by reference, and other reports that may be filed from time to time with the Securities and Exchange Commission. The Company assumes no obligation to update the forward-looking information contained in this release.

ctg-g

Investors: John Laubacker
Chief Financial Officer
john.laubacker@ctg.com
(716) 887-7368

Media: Amanda LeBlanc
Vice President, Marketing
amanda.leblanc@ctg.com 
(225) 772-8865




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Computer Task Group, Incorporated via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Oboya participates in China International Import Expo1.11.2018 15:00Pressmeddelande

Newsletter Lerum, 1th November 2018 Oboya Horticulture Industries AB (publ) ("Oboya"), a global manufacturer and supplier of products and services for the cultivation industry, will participate in China International Import Expo in Shanghai, China. China International Import Expo (CIIE) is a six-day fair held from November 5 to November 10, 2018 at the National Convention & Exhibition Center in Shanghai, China. This fair brings together companies, exhibitors and professional buyers from all over the world. The fair creates new channels for companies from different countries and regions and provides the opportunity to do business, strengthen cooperation and promote trade. Oboya's strategy is to work globally in the various markets in the cultivation and flower industry, which it's important for Oboya to participate in the major trade shows. Oboya has its own booth at the fair and will show/marketing the European cultivation products and technology to the Chinese market. The purpose of t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum